A retrospective, single-center study assessing the safety and efficacy of anti-IL6 tocilizumab in subjects with COVID-19
Latest Information Update: 15 Jul 2020
At a glance
- Drugs Tocilizumab (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions; Therapeutic Use
- 15 Jul 2020 New trial record
- 08 Jul 2020 Results published in the Journal of Infection